Clinical trials
Arthritis, Juvenile trials in Spain
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
48 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 2 |
| 2003 | 1 |
| 2008 | 2 |
| 2009 | 5 |
| 2010 | 1 |
| 2012 | 1 |
| 2013 | 5 |
| 2014 | 2 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 5 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 3 |
| 2025 | 4 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 27 |
| Recruiting | 12 |
| Active, not recruiting | 4 |
| Terminated | 3 |
| Not yet recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hoffmann-La Roche | 7 |
| Novartis Pharmaceuticals | 7 |
| Pfizer | 5 |
| AbbVie | 4 |
| Eli Lilly and Company | 4 |
| Bristol-Myers Squibb | 3 |
| Swedish Orphan Biovitrum | 3 |
| Alfasigma S.p.A. | 2 |
| Amgen | 2 |
| Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Arthritis, Juvenile | 48 |
| Arthritis | 10 |
| Macrophage Activation Syndrome | 3 |
| Arthritis, Psoriatic | 2 |
| Behcet Syndrome | 2 |
| Still's Disease, Adult-Onset | 2 |
| Arthralgia | 1 |
| Arthritis, Rheumatoid | 1 |
| Bronchiolitis Obliterans Syndrome | 1 |
| Castleman Disease | 1 |
Trials
Showing 26 to 48 of 48. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.